Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study-Reference-Cited by-同舟云学术

Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study

Published:2012-12 Issue:12 Volume:23 Page:3069-3074
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Alba E.,Calvo L.,Albanell J.,De la Haba J.R.,Arcusa Lanza A.,Chacon J.I.,Sanchez-Rovira P.,Plazaola A.,Lopez Garcia-Asenjo J.A.,Bermejo B.,Carrasco E.,Lluch A.

Funder

Pfizer S.L.U.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/12/3069/13786179/mds132.pdf

Reference43 articles.

1. Molecular portraits of human breast tumours;Perou;Nature,2000

2. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc Natl Acad Sci USA,2001

3. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc Natl Acad Sci USA,2003